-transparent.png){kind=logo}
Four patients of delusional disorder, somatic type, were treated with clomipramine 60-120 mg/day. All patients showed marked clinical improvement after 27-57 days of clomipramine treatment. In one case, previous treatments by various antipsychotic drugs including pimozide had been unsuccessful. This report suggests that clomipramine is effective at least for some patients with delusional disorder, somatic type, including pimozide-resistant cases. It is also suggested that there is some association between delusional disorder, somatic type, and serotonergic dysfunction.
Related Publications
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
March 1988,
Journal of the American Academy of Child and Adolescent Psychiatry,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
July 2004,
Human psychopharmacology,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
May 2008,
Pharmacopsychiatry,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
October 2019,
Dermatology online journal,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
March 2011,
Acta dermato-venereologica,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
September 2008,
Journal of psychopharmacology (Oxford, England),
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
June 2013,
The Journal of nervous and mental disease,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
April 1996,
The American journal of psychiatry,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
October 2012,
Acta neuropsychiatrica,
T Wada, and
S Kawakatsu, and
T Nadaoka, and
N Okuyama, and
K Otani
January 2010,
Clinical neuropharmacology,
